Quantitative targeted absolute proteomics-based large-scale quantification of proline-hydroxylated α-fibrinogen in plasma for pancreatic cancer diagnosis

Journal of Proteome Research

Volumn 12, Issue 2, 2013, Pages 753-762

  Yoneyama, Toshihiro ^a   Ohtsuki, Sumio ^a,c   Ono, Masaya ^b   Ohmine, Ken ^a   Uchida, Yasuo ^a   Yamada, Tesshi ^b   Tachikawa, Masanori ^a   Terasaki, Tetsuya ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^c KUMAMOTO UNIVERSITY   (Japan)

Author keywords

fibrinogen; hydroxylated proline; pancreatic cancer; post translational modification; quantification; selected multiple reaction monitoring

Indexed keywords

FIBRINOGEN; HYDROGEN PEROXIDE; METHIONINE; PROLINE HYDROXYLATED ALPHA FIBRINOGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; HYDROXYLATION; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MALE; MONITORING; MULTIPLE REACTION MONITORING; OXIDATION; PANCREAS CANCER; PRIORITY JOURNAL; PROTEOMICS; QUANTITATIVE ANALYSIS; SELECTED REACTION MONITORING; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

AGED; AGED, 80 AND OVER; CA-19-9 ANTIGEN; CASE-CONTROL STUDIES; FEMALE; FIBRINOGEN; HUMANS; HYDROGEN PEROXIDE; HYDROXYLATION; MALE; METHIONINE; MIDDLE AGED; NEOPLASM STAGING; OXIDATION-REDUCTION; PANCREATIC NEOPLASMS; PROGNOSIS; PROLINE; PROTEOMICS; TUMOR MARKERS, BIOLOGICAL;

EID: 84873396753     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr3008144     Document Type: Article

References (37)

1. Zhang, J.; Guy, M. J.; Norman, H. S.; Chen, Y. C.; Xu, Q.; Dong, X.; Guner, H.; Wang, S.; Kohmoto, T.; Young, K. H.; Moss, R. L.; Ge, Y. Top-down quantitative proteomics identified phosphorylation of cardiac troponin I as a candidate biomarker for chronic heart failure J. Proteome Res. 2011, 10 (9) 4054-65
2. Ogata, Y.; Heppelmann, C. J.; Charlesworth, M. C.; Madden, B. J.; Miller, M. N.; Kalli, K. R.; Cilby, W. A.; Bergen, H. R., 3rd; Saggese, D. A.; Muddiman, D. C. Elevated levels of phosphorylated fibrinogen-alpha-isoforms and differential expression of other post-translationally modified proteins in the plasma of ovarian cancer patients J. Proteome Res. 2006, 5 (12) 3318-25
3. Polanski, M.; Anderson, N. L. A list of candidate cancer biomarkers for targeted proteomics Biomarker Insights 2007, 1, 1-48
4. Siegel, R.; DeSantis, C.; Virgo, K.; Stein, K.; Mariotto, A.; Smith, T.; Cooper, D.; Gansler, T.; Lerro, C.; Fedewa, S.; Lin, C.; Leach, C.; Cannady, R. S.; Cho, H.; Scoppa, S.; Hachey, M.; Kirch, R.; Jemal, A.; Ward, E. Cancer treatment and survivorship statistics CA Cancer J. Clin. 2012, 62 (4) 220-41
5. Ballehaninna, U. K.; Chamberlain, R. S. Serun CA 19-9 as a biomarker for pancreatic cancer-A comprehensive review Indian J. Surg. Oncol. 2011, 2 (2) 88-100
6. Gorres, K. L.; Raines, R. T. Prolyl 4-hydroxylase Crit. Rev. Biochem. Mol. Biol. 2010, 45 (2) 106-24
7. Jaakkola, P.; Mole, D. R.; Tian, Y. M.; Wilson, M. I.; Gielbert, J.; Gaskell, S. J.; Kriegsheim, A.; Hebestreit, H. F.; Mukherji, M.; Schofield, C. J.; Maxwell, P. H.; Pugh, C. W.; Ratcliffe, P. J. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation Science 2001, 292 (5516) 468-72
8. Qi, H. H.; Ongusaha, P. P.; Myllyharju, J.; Cheng, D.; Pakkanen, O.; Shi, Y.; Lee, S. W.; Peng, J. Prolyl 4-hydroxylation regulates Argonaute 2 stability Nature 2008, 455 (7211) 421-4
9. Lopez-Vera, E.; Walewska, A.; Skalicky, J. J.; Olivera, B. M.; Bulaj, G. Role of hydroxyprolines in the in vitro oxidative folding and biological activity of conotoxins Biochemistry 2008, 47 (6) 1741-51
10. Ono, M.; Shitashige, M.; Honda, K.; Isobe, T.; Kuwabara, H.; Matsuzuki, H.; Hirohashi, S.; Yamada, T. Label-free quantitative proteomics using large peptide data sets generated by nanoflow liquid chromatography and mass spectrometry Mol. Cell. Proteomics 2006, 5 (7) 1338-47
11. Ono, M.; Matsubara, J.; Honda, K.; Sakuma, T.; Hashiguchi, T.; Nose, H.; Nakamori, S.; Okusaka, T.; Kosuge, T.; Sata, N.; Nagai, H.; Ioka, T.; Tanaka, S.; Tsuchida, A.; Aoki, T.; Shimahara, M.; Yasunami, Y.; Itoi, T.; Moriyasu, F.; Negishi, A.; Kuwabara, H.; Shoji, A.; Hirohashi, S.; Yamada, T. Prolyl 4-hydroxylation of alpha-fibrinogen: a novel protein modification revealed by plasma proteomics J. Biol. Chem. 2009, 284 (42) 29041-9
12. Fan, H.; Li, R.; Gu, Y.; Si, D.; Liu, C. Quantitation of bentysrepinine (Y101) in rat plasma by liquid chromatography tandem mass spectrometry: application to pharmacokinetic study J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 2012, 889-890, 103-9
13. Keshishian, H.; Addona, T.; Burgess, M.; Kuhn, E.; Carr, S. A. Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution Mol. Cell. Proteomics 2007, 6 (12) 2212-29
14. Andersen, J. S.; Wilkinson, C. J.; Mayor, T.; Mortensen, P.; Nigg, E. A.; Mann, M. Proteomic characterization of the human centrosome by protein correlation profiling Nature 2003, 426 (6966) 570-4
15. Zhang, G.; Fang, B.; Liu, R. Z.; Lin, H.; Kinose, F.; Bai, Y.; Oguz, U.; Remily-Wood, E. R.; Li, J.; Altiok, S.; Eschrich, S.; Koomen, J.; Haura, E. B. Mass spectrometry mapping of epidermal growth factor receptor phosphorylation related to oncogenic mutations and tyrosine kinase inhibitor sensitivity J. Proteome Res. 2011, 10 (1) 305-19
16. Kamiie, J.; Ohtsuki, S.; Iwase, R.; Ohmine, K.; Katsukura, Y.; Yanai, K.; Sekine, Y.; Uchida, Y.; Ito, S.; Terasaki, T. Quantitative atlas of membrane transporter proteins: development and application of a highly sensitive simultaneous LC/MS/MS method combined with novel in-silico peptide selection criteria Pharm. Res. 2008, 25 (6) 1469-83
17. Ohtsuki, S.; Uchida, Y.; Kubo, Y.; Terasaki, T. Quantitative targeted absolute proteomics-based ADME research as a new path to drug discovery and development: methodology, advantages, strategy, and prospects J. Pharm. Sci. 2011, 100 (9) 3547-59
18. Matsubara, J.; Honda, K.; Ono, M.; Sekine, S.; Tanaka, Y.; Kobayashi, M.; Jung, G.; Sakuma, T.; Nakamori, S.; Sata, N.; Nagai, H.; Ioka, T.; Okusaka, T.; Kosuge, T.; Tsuchida, A.; Shimahara, M.; Yasunami, Y.; Chiba, T.; Yamada, T. Identification of adipophilin as a potential plasma biomarker for colorectal cancer using label-free quantitative mass spectrometry and protein microarray Cancer Epidemiol., Biomarkers Prev. 2011, 20 (10) 2195-203
19. Murakoshi, Y.; Honda, K.; Sasazuki, S.; Ono, M.; Negishi, A.; Matsubara, J.; Sakuma, T.; Kuwabara, H.; Nakamori, S.; Sata, N.; Nagai, H.; Ioka, T.; Okusaka, T.; Kosuge, T.; Shimahara, M.; Yasunami, Y.; Ino, Y.; Tsuchida, A.; Aoki, T.; Tsugane, S.; Yamada, T. Plasma biomarker discovery and validation for colorectal cancer by quantitative shotgun mass spectrometry and protein microarray Cancer Sci, 2011, 102 (3) 630-8
20. Mawuenyega, K. G.; Kaji, H.; Yamuchi, Y.; Shinkawa, T.; Saito, H.; Taoka, M.; Takahashi, N.; Isobe, T. Large-scale identification of Caenorhabditis elegans proteins by multidimensional liquid chromatography-tandem mass spectrometry J, Proteome Res, 2003, 2 (1) 23-35
21. Ji, J. A.; Zhang, B.; Cheng, W.; Wang, Y. J. Methionine, tryptophan, and histidine oxidation in a model protein, PTH: mechanisms and stabilization J. Pharm. Sci. 2009, 98 (12) 4485-500
22. Zong, W.; Liu, R.; Wang, M.; Zhang, P.; Sun, F.; Tian, Y. The oxidative products of methionine as site and content biomarkers for peptide oxidation J, Pept, Sci, 2010, 16 (3) 148-52
23. Kawakami, H.; Ohtsuki, S.; Kamiie, J.; Suzuki, T.; Abe, T.; Terasaki, T. Simultaneous absolute quantification of 11 cytochrome P450 isoforms in human liver microsomes by liquid chromatography tandem mass spectrometry with in silico target peptide selection J. Pharm. Sci. 2011, 100 (1) 341-52
24. Fusaro, V. A.; Mani, D. R.; Mesirov, J. P.; Carr, S. A. Prediction of high-responding peptides for targeted protein assays by mass spectrometry Nat. Biotechnol. 2009, 27 (2) 190-8
25. Ohtsuki, S.; Schaefer, O.; Kawakami, H.; Inoue, T.; Liehner, S.; Saito, A.; Ishiguro, N.; Kishimoto, W.; Ludwig-Schwellinger, E.; Ebner, T.; Terasaki, T. Simultaneous absolute protein quantification of transporters, cytochromes P450, and UDP-glucuronosyltransferases as a novel approach for the characterization of individual human liver: comparison with mRNA levels and activities Drug Metab. Dispos. 2012, 40 (1) 83-92
26. Kawakami, H.; Kamiie, J.; Yasuno, K.; Kobayashi, R.; Aihara, N.; Shirota, K. Dynamics of absolute amount of nephrin in a single podocyte in puromycin aminonucleoside nephrosis rats calculated by quantitative glomerular proteomics approach with selected reaction monitoring mode Nephrol. Dial. Transplant. 2012, 27 (4) 1324-30
27. Kuhn, E.; Wu, J.; Karl, J.; Liao, H.; Zolg, W.; Guild, B. Quantification of C-reactive protein in the serum of patients with rheumatoid arthritis using multiple reaction monitoring mass spectrometry and 13C-labeled peptide standards Proteomics 2004, 4 (4) 1175-86
28. Wang, M. Z.; Wu, J. Q.; Dennison, J. B.; Bridges, A. S.; Hall, S. D.; Kornbluth, S.; Tidwell, R. R.; Smith, P. C.; Voyksner, R. D.; Paine, M. F.; Hall, J. E. A gel-free MS-based quantitative proteomic approach accurately measures cytochrome P450 protein concentrations in human liver microsomes Proteomics 2008, 8 (20) 4186-96
29. Langenfeld, E.; Zanger, U. M.; Jung, K.; Meyer, H. E.; Marcus, K. Mass spectrometry-based absolute quantification of microsomal cytochrome P450 2D6 in human liver Proteomics 2009, 9 (9) 2313-23
30. Ciccimaro, E.; Hanks, S. K.; Yu, K. H.; Blair, I. A. Absolute quantification of phosphorylation on the kinase activation loop of cellular focal adhesion kinase by stable isotope dilution liquid chromatography/mass spectrometry Anal. Chem. 2009, 81 (9) 3304-13
31. Fahling, M.; Mrowka, R.; Steege, A.; Nebrich, G.; Perlewitz, A.; Persson, P. B.; Thiele, B. J. Translational control of collagen prolyl 4-hydroxylase-alpha(I) gene expression under hypoxia J. Biol. Chem. 2006, 281 (36) 26089-101
32. Koong, A. C.; Mehta, V. K.; Le, Q. T.; Fisher, G. A.; Terris, D. J.; Brown, J. M.; Bastidas, A. J.; Vierra, M. Pancreatic tumors show high levels of hypoxia Int. J.Radiat. Oncol. Biol. Phys. 2000, 48 (4) 919-22
33. Su, Y.; Loos, M.; Giese, N.; Hines, O. J.; Diebold, I.; Gorlach, A.; Metzen, E.; Pastorekova, S.; Friess, H.; Buchler, P. PHD3 regulates differentiation, tumour growth and angiogenesis in pancreatic cancer Br. J. Cancer 2010, 103 (10) 1571-9
34. Gossage, L.; Zaitoun, A.; Fareed, K. R.; Turley, H.; Aloysius, M.; Lobo, D. N.; Harris, A. L.; Madhusudan, S. Expression of key hypoxia sensing prolyl-hydroxylases PHD1, -2 and -3 in pancreaticobiliary cancer Histopathology 2010, 56 (7) 908-20
35. Guo, Q.; Zhang, B.; Dong, X.; Xie, Q.; Guo, E.; Huang, H.; Wu, Y. Elevated levels of plasma fibrinogen in patients with pancreatic cancer: possible role of a distant metastasis predictor Pancreas 2009, 38 (3) e75-9
36. Bloomston, M.; Zhou, J. X.; Rosemurgy, A. S.; Frankel, W.; Muro-Cacho, C. A.; Yeatman, T. J. Fibrinogen gamma overexpression in pancreatic cancer identified by large-scale proteomic analysis of serum samples Cancer Res. 2006, 66 (5) 2592-9
37. Ni, X. G.; Bai, X. F.; Mao, Y. L.; Shao, Y. F.; Wu, J. X.; Shan, Y.; Wang, C. F.; Wang, J.; Tian, Y. T.; Liu, Q.; Xu, D. K.; Zhao, P. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer Eur. J. Surg. Oncol. 2005, 31 (2) 164-9